Form 8-K - Current report:
SEC Accession No. 0001558370-25-003405
Filing Date
2025-03-21
Accepted
2025-03-20 20:30:51
Documents
17
Period of Report
2025-03-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K armp-20250320x8k.htm   iXBRL 8-K 37339
2 EX-99.1 armp-20250320xex99d1.htm EX-99.1 222419
3 GRAPHIC armp-20250320xex99d1001.jpg GRAPHIC 2307
  Complete submission text file 0001558370-25-003405.txt   432506

Data Files

Seq Description Document Type Size
4 EX-101.SCH armp-20250320.xsd EX-101.SCH 4402
5 EX-101.DEF armp-20250320_def.xml EX-101.DEF 2858
6 EX-101.LAB armp-20250320_lab.xml EX-101.LAB 11593
7 EX-101.PRE armp-20250320_pre.xml EX-101.PRE 11333
19 EXTRACTED XBRL INSTANCE DOCUMENT armp-20250320x8k_htm.xml XML 4656
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 25758299
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)